Substituted pyrimidines as ligands of adenosine receptors
    2.
    发明申请
    Substituted pyrimidines as ligands of adenosine receptors 失效
    取代的嘧啶作为腺苷受体的配体

    公开(公告)号:US20070032510A1

    公开(公告)日:2007-02-08

    申请号:US10574436

    申请日:2004-10-01

    CPC分类号: C07D239/42

    摘要: The invention provides a compound of formula (I) wherein R and R′ are selected from hydrogen, alkyl, alkenyl, alkynyl, or aryl; R″ and R′″ are selected from hydrogen, acyl, thio-acyl, seleno-acyl, alkyl, alkenyl, alkynyl, or aryl; or a pharmaceutically acceptable salt thereof, to interact with the adenosine receptors in the beneficial treatment and/or prevention of a (dis)order arising from the said receptors. The invention further provides pharmaceutical compositions comprising said compounds. The invention also relates to the use of said compositions for treating an/or preventing a variety of diseases.

    摘要翻译: 本发明提供式(I)化合物,其中R和R'选自氢,烷基,烯基,炔基或芳基; R“和R”'选自氢,酰基,硫代酰基,硒酰基,烷基,烯基,炔基或芳基; 或其药学上可接受的盐在有益治疗和/或预防由所述受体产生的(dis)顺序的情况下与腺苷受体相互作用。 本发明还提供包含所述化合物的药物组合物。 本发明还涉及所述组合物用于治疗/或预防各种疾病的用途。